Kanyr Pharma

Private

MontrealHealthcare & Life Scienceshttps://kanyrpharma.com/

Last Round

Grant

Jun 5, 2023

Total Funding Raised

$680,000

Company Overview

Kanyr Pharma is a biotechnology company that develops innovative protein tyrosine phosphatase (PTP) inhibitor-based therapies for the treatment of cancer and other human diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryprotein tyrosine phosphatasePTP inhibitorsimmunotherapysmall molecule inhibitorsoncologyundruggable targetspreclinical researchbiotech startupdrug pipelinetherapeutic developmentpharma licensingsolid tumor therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kanyr Pharma Comparables

Compare Kanyr Pharma with similar companies based on industry and business-model similarity.

Kanyr Pharma comparables — related companies by embedding similarity
Company	Similarity	Market Cap
DepYmed, Inc.	84%
BridgeBio Pharma, Inc.	76%
Jacobio Pharmaceuticals Group Co Ltd	72%

View all Comparables

Kanyr Pharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jun 5, 2023
Grant	Jun 17, 2020

View all Funding Rounds

Kanyr Pharma Investors

Notable investors and investment history

Kanyr Pharma investors
Investor	Rounds
Consortium Québécois sur la découverte du médicament	Grant
Mitacs	Grant
Natural Sciences and Engineering Research Council of Canada	Grant
MEDTEQ+	Grant

View all Investors

Kanyr Pharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Kanyr Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kanyr Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal

Employee Range1

Year Founded2013

Last FundingJun 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?